Poly(hydroxy acid)s are a family of biocompatible and (bio)degradable polyesters with various outcomes in different domains of application. To date, poly(hydroxy acid)s are best prepared by ring‐opening polymerization (ROP) of the corresponding cyclic esters. Using racemic chiral monomers featuring side‐chain groups enables to access, providing a stereoselective catalyst/initiator system is implemented, stereoregular functional polymers, thereby improving their physico–chemical properties, and ultimately, widening their range of uses. Here, we highlight a few important advances in metal‐mediated stereoselective ROP of cyclic esters towards the synthesis of (functional) stereoregular poly(hydroxy acid)s that have recently been disclosed, emphasizing on (functional) β‐ and γ‐lactones, diolide and O‐carboxyanhydride (OCA) monomers and yttrium‐based catalysis. Fine‐tuning of the substituents flanked on the catalyst ligand enables reaching poly(hydroxy acid)s with syndiotactic and also isotactic microstructures. The stereocontrol mechanisms at work and their probable origin, relying on steric but also electronic factors imparted in particular by the ligand substituents, are discussed. Taking advantage of such stereoselective ROPs, original copoly(hydroxy acid)s with gradient or alternated patterns then become accessible from the use of mixtures of chemically different, oppositely configured enantiopure monomers.
Polyhydroxyalkanoates (PHAs) are a unique class of polyesters especially due to their chemical diversity imparted by their side-chain substituent that provides a handle to tune their properties, such as their...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.